What Is The Function Of Mcts In Cannabinoid Transdermal Patches? Boost Bioavailability With Superior Lipid Carriers

Medium-Chain Triglycerides (MCTs) function primarily as high-efficiency carriers and absorption enhancers within cannabinoid transdermal patches. Their specific role is to increase the solubility of lipophilic ingredients, such as CBD, enabling them to overcome the skin's natural resistance and successfully enter the bloodstream.

Because cannabinoids are naturally water-resistant (hydrophobic), they struggle to penetrate the skin on their own. MCTs bridge this gap by dissolving the active ingredients and facilitating their transport across the skin barrier, directly improving bioavailability and systemic circulation.

The Core Challenge: Hydrophobicity

The Nature of Cannabinoids

Cannabinoids, including CBD, are lipophilic substances. This means they dissolve in fats and oils but are naturally hydrophobic (water-repelling).

The Skin's Defense Mechanism

Your skin is designed to be a protective barrier. It presents physicochemical obstacles that prevent foreign substances from entering the body.

The Delivery Problem

Without a mechanism to modify their chemical behavior, cannabinoids tend to sit on the surface of the skin rather than passing through it.

How MCTs Facilitate Delivery

Increasing Solubility

MCTs act as a solvent vehicle. They effectively dissolve the cannabinoid isolate or distillate, ensuring the active ingredient is evenly distributed within the patch matrix.

Overcoming Physicochemical Barriers

By encapsulating the cannabinoid in a lipid-based carrier, MCTs help the compound navigate the skin's layers. This allows the formulation to bypass the stratum corneum (the outer layer of skin) more effectively.

Enhancing Bioavailability

The ultimate function of adding MCTs is to ensure the active ingredients reach systemic circulation. By improving the rate and extent of absorption, MCTs ensure the user receives the intended therapeutic effect.

Understanding the Trade-offs

Dependence on Carrier Efficiency

The effectiveness of a transdermal patch is heavily reliant on the quality and ratio of the carrier oil.

The Limits of Absorption

While MCTs significantly enhance delivery, they do not remove the skin barrier entirely. The formulation must still account for the skin's natural limits regarding how much of a substance can be absorbed over a specific timeframe.

Making the Right Choice for Your Formulation

To maximize the efficacy of your transdermal product, consider the following based on your formulation goals:

If your primary focus is bioavailability: Prioritize the ratio of MCTs to cannabinoids to ensure maximum solubility, preventing the active ingredient from crystallizing or remaining on the skin surface.
If your primary focus is consistent dosing: Use MCTs to create a homogeneous mixture, ensuring that every square centimeter of the patch contains an equal amount of the active cannabinoid for reliable systemic delivery.

MCTs are not just a filler ingredient; they are the critical vehicle that transforms a topical application into a systemic delivery system.

Summary Table:

Feature	Role of MCTs in Transdermal Patches	Benefit to Formulation
Solubility	Acts as a high-efficiency solvent vehicle	Prevents crystallization of lipophilic cannabinoids
Skin Penetration	Overcomes the stratum corneum barrier	Facilitates transport through skin layers
Bioavailability	Enhances systemic circulation access	Ensures the user receives the intended therapeutic dose
Dosing Consistency	Creates a homogeneous lipid mixture	Guarantees uniform distribution of active ingredients

Elevate Your Transdermal Formulations with Enokon

Maximize the efficacy of your cannabinoid products with Enokon, a trusted manufacturer and R&D specialist. We provide professional wholesale and custom transdermal patch solutions—ranging from Lidocaine, Menthol, and Capsicum for pain relief to innovative CBD-compatible carriers, Eye Protection, and Detox patches.

Our team is ready to help you optimize solubility and bioavailability for your target market. (Please note: We do not produce microneedle technology.)

Ready to develop high-performance patches? Contact us today to discuss your custom R&D needs!

References

Pim Sermsaksasithorn, Nattiya Hirankarn. Efficacy and Safety of Cannabis Transdermal Patch for Alleviating Psoriasis Symptoms: Protocol for a Randomized Controlled Trial (CanPatch).. DOI: 10.1159/000539492

This article is also based on technical information from Enokon Knowledge Base .